Aventisub LLC
General
Total Cases37
Active Cases--
Patents355
--
--
--
Ratings
Experience
Grade
Trend
DCT
L4
A
PTAB
L5
E
CAFC
L4
A
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 06/17/24 | SO ORDERED Granting 1098 Joint Stipulation to Substitute Party and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/17/2024. (nms) (Entered: 06/17/2024) | |
| 06/10/24 | Joint Stipulation to Substitute Party and Amend Case Caption, by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. (Higgins, James) Modified on 6/10/2024 (nms). Modified on 6/10/2024 (nms). (Entered: 06/10/2024) | |
| 06/10/24 | CORRECTING ENTRY: The stipulation filed at D.I. 1097 has been removed from the docket per the corrected filing at D.I. 1098 . (nms) (Entered: 06/10/2024) | |
| 05/24/24 | REPLY BRIEF re 1092 MOTION for Review of Taxation of Costs filed by Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Czerwonka, Scott) (Entered: 05/24/2024) | |
| 05/14/24 | ANSWERING BRIEF in Opposition re 1092 MOTION for Review of Taxation of Costs, filed by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. Reply Brief due date per Order re D.I. 1094 5/24/2024. (Higgins, James) Modified on 5/21/2024 (nms). (Entered: 05/14/2024) | |
| 04/26/24 | STIPULATION to Extend Briefing Deadlines - filed by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc.. (Higgins, James) Modified on 4/26/2024 (nms). (Entered: 04/26/2024) | |
| 04/26/24 | SO ORDERED, re 1094 STIPULATION to Extend Briefing Deadlines (*Reset Briefing Schedule: re 1092 MOTION for Review of Taxation of Costs. Answering Brief due 5/14/2024, Reply Brief due 5/24/2024). Signed by Judge Richard G. Andrews on 4/26/2024. (nms) (Entered: 04/26/2024) | |
| 04/19/24 | OPENING BRIEF in Support re 1092 MOTION for Review of Taxation of Costs filed by Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi, Sanofi-Aventis U.S. LLC.Answering Brief/Response due date per Local Rules is 5/3/2024. (Czerwonka, Scott) (Entered: 04/19/2024) | |
| 04/19/24 | MOTION for Review of Taxation of Costs - filed by Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi, Sanofi-Aventis U.S. LLC. (Czerwonka, Scott) (Entered: 04/19/2024) | |
| 04/12/24 | [SEALED] Clerk's Taxation of Costs in amount of $ 23,254.49 against Plaintiffs. Request for Costs 1083 is GRANTED IN PART/DENIED IN PART in favor of Sanofi, Sanofi-Aventis U.S. LLC, f/d/b/a Aventis Pharmaceuticals Inc., and Regeneron Pharmaceuticals Inc. (emailed to the parties). (dmp, ) (Entered: 04/12/2024) |